The role of adjuvant in mediating antigen structure and stability

Journal of Pharmaceutical Sciences

Volumn 101, Issue 4, 2012, Pages 1391-1399

  Braun, Latoya Jones ^a   Eldridge, Aimee M ^b,c   Cummiskey, Jessica ^a   Arthur, Kelly K ^a,d   Wuttke, Deborah S ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c BOWDOIN COLLEGE   (United States)

^d AMGEN INC   (United States)

Author keywords

Adsorption; Aluminum containing adjuvant; Calorimetry (DSC); Fluorescence spectroscopy; NMR spectroscopy; Protein stability; Protein structure; Vaccine

Indexed keywords

8 ANILINO 1 NAPHTHALENESULFONIC ACID; ALUMINUM; IMMUNOLOGICAL ADJUVANT;

ADSORPTION; ANTIGEN STRUCTURE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; FLUORESCENCE SPECTROSCOPY; HYDROPHOBICITY; IONIC STRENGTH; NONHUMAN; PROTEIN INTERACTION; PROTEIN STABILITY; STATIC ELECTRICITY; THERMOSTABILITY;

EID: 84857508184     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23039     Document Type: Article

References (26)

1. Ausar SF, Chan J, Hoque W, James O, Jayasundara K, Harper K. Application of extrinsic fluorescence spectroscopy for the high throughput formulation screening of aluminum-adjuvanted vaccines. J Pharm Sci 100(2):431-440.
2. Jones LS, Peek LJ, Power J, Markham A, Yazzie B, Middaugh CR. 2005. Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens. J Biol Chem 280(14):13406-13414.
3. Peek LJ, Martin TT, Elk Nation C, Pegram SA, Middaugh CR. 2007. Effects of stabilizers on the destabilization of proteins upon adsorption to aluminum salt adjuvants. J Pharm Sci 96(3):547-557.
4. Vessely C, Estey T, Randolph TW, Henderson I, Cooper J, Nayar R, Braun LJ, Carpenter JF. 2009. Stability of a trivalent recombinant protein vaccine formulation against botulinum neurotoxin during storage in aqueous solution. J Pharm Sci 98(9):2970-2993.
5. Matsumura M, Matthews BW. 1989. Control of enzyme activity by an engineered disulfide bond. Science 243(4892):792-794.
6. Bell JA, Wilson KP, Zhang XJ, Faber HR, Nicholson H, Matthews BW. 1991. Comparison of the crystal structure of bacteriophage T4 lysozyme at low, medium, and high ionic strengths. Proteins 10(1):10-21.
7. 1H NMR assignments and secondary structure for T4-lysozyme. J Magn Reson B 108(2):143-154.
8. 15N NMR resonances of bacteriophage T4 lysozyme. Biochemistry 29(27):6341-6362.
9. Alber T, Matthews BW. 1987. Structure and thermal stability of phage T4 lysozyme. Methods Enzymol 154:511-533.
10. Tugarinov V, Kay LE. 2003. Quantitative NMR studies of high molecular weight proteins: Application to domain orientation and ligand binding in the 723 residue enzyme malate synthase G. J Mol Biol 327(5):1121-1133.
11. Wetzel R, Perry LJ, Baase WA, Becktel WJ. 1988. Disulfide bonds and thermal stability in T4 lysozyme. Proc Natl Acad Sci U S A 85(2):401-405.
12. Llinas M, Marqusee S. 1998. Subdomain interactions as a determinant in the folding and stability of T4 lysozyme. Protein Sci 7(1):96-104.
13. Uversky VN, Leontiev VV, Gudkov AT. 1992. Triple point mutation Asp10→His, Asn101→Asp, Arg148→Ser in T4 phage lysozyme leads to the molten globule. Protein Eng 5(8):781-783.
14. Baase WA, Liu L, Tronrud DE, Matthews BW. Lessons from the lysozyme of phage T4. Protein Sci 19(4):631-641.
15. Matsumura M, Becktel WJ, Matthews BW. 1988. Hydrophobic stabilization in T4 lysozyme determined directly by multiple substitutions of Ile 3. Nature 334(6181):406-410.
16. Matsumura M, Wozniak JA, Sun DP, Matthews BW. 1989. Structural studies of mutants of T4 lysozyme that alter hydrophobic stabilization. J Biol Chem 264(27):16059-16066.
17. Chang M, Shi Y, Nail SL, HogenEsch H, Adams SB, White JL, Hem SL. 2001. Degree of antigen adsorption in the vaccine or interstitial fluid and its effect on the antibody response in rabbits. Vaccine 19(20-22):2884-2889.
18. Heimlich JM, Regnier FE, White JL, Hem SL. 1999. The in vitro displacement of adsorbed model antigens from aluminium-containing adjuvants by interstitial proteins. Vaccine 17(22):2873-2881.
19. Iyer S, HogenEsch H, Hem SL. 2003. Relationship between the degree of antigen adsorption to aluminum hydroxide adjuvant in interstitial fluid and antibody production. Vaccine 21(11-12):1219-1223.
20. Morefield GL, Jiang D, Romero-Mendez IZ, Geahlen RL, Hogenesch H, Hem SL. 2005. Effect of phosphorylation of ovalbumin on adsorption by aluminum-containing adjuvants and elution upon exposure to interstitial fluid. Vaccine 23(12):1502-1506.
21. Egan PM, Belfast MT, Gimenez JA, Sitrin RD, Mancinelli RJ. 2009. Relationship between tightness of binding and immunogenicity in an aluminum-containing adjuvant-adsorbed hepatitis B vaccine. Vaccine 27(24):3175-3180.
22. Hansen B, Belfast M, Soung G, Song L, Egan PM, Capen R, Hogenesch H, Mancinelli R, Hem SL. 2009. Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response. Vaccine 27(6):888-892.
23. Hansen B, Malyala P, Singh M, Sun Y, Srivastava I, Hogenesch H, Hem SL. Effect of the strength of adsorption of HIV 1 SF162dV2gp140 to aluminum-containing adjuvants on the immune response. J Pharm Sci 100(8):3245-3250.
24. Hansen B, Sokolovska A, HogenEsch H, Hem SL. 2007. Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response. Vaccine 25(36):6618-6624.
25. Shi Y, HogenEsch H, Hem SL. 2001. Change in the degree of adsorption of proteins by aluminum-containing adjuvants following exposure to interstitial fluid: Freshly prepared and aged model vaccines. Vaccine 20(1-2):80-85.
26. McGuire J, Wahlgren M, Arnebrant T. 1995. Structural stability effects on the adsorption and dodecyltrimethylammonium bromide-mediated elutability of bacteriophage T4 lysozyme at silica surfaces. J Colloid Interface Sci 170.